MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xjtc.2026.102197

Медицинская библиотека · JTCVS techniques · 2026

Outcomes of transatrial transcatheter mitral valve replacement with a balloon-expandable valve for severe mitral annular calcification.

Curran Brett F, Juarez Casso Fernando M, Schaff Hartzell V, Saran Nishant, Rowse Phillip G, Bagameri Gabor, Greason Kevin L, Daly Richard C, Guerrero Mayra, Crestanello Juan A

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To evaluate operative and midterm outcomes, including 1-, 3-, and 5-year survival, of transatrial transcatheter mitral valve replacement (TA-TMVR) with a balloon-expandable valve for severe mitral annular calcification (MAC).

METHODS

We retrospectively reviewed patients with severe MAC who underwent TA-TMVR from 2014 to 2024 using a balloon-expandable prosthesis.

RESULTS

Twenty-five patients (68% were female, mean age 75 years) had TA-TMVR for mitral valve disease (92% severe stenosis, 52% moderate-to-severe mitral regurgitation). Previous cardiac surgery was common (48%). Median Society of Thoracic Surgeons Predicted Risk of Operative Mortality was 9% (2%-26%). Most patients were New York Heart Association class III or IV (76%). Preoperative left ventricular ejection fraction was 66%. Concomitant procedures were performed in 68% of cases (aortic valve replacement in 11, septal myectomy in 6, other procedures in 9). A SAPIEN 3 valve was used in 24 patients; most were modified with a felt skirt to improve sealing. Anterior leaflet resection was performed in 24 patients. Operative mortality was 12%. Median length of stay was 14 days. Postoperative left ventricular ejection fraction was 64%, and the mean mitral valve gradient was 5 mm Hg. Paravalvular leak were observed in 6 patients; 3 underwent successful transcatheter closure. One of these patients required a percutaneous valve-in-valve for on-going hemolysis. One-, 3-, and 5-year survival was 68%, 59.5%, and 50.6%, respectively.

CONCLUSIONS

TA-TMVR with a balloon-expandable valve is a feasible and durable option for high-risk patients with severe MAC and those requiring concomitant procedures, offering an alternative to conventional surgery in anatomically complex or otherwise-inoperable cases.

Для цитирования: Curran Brett F, Juarez Casso Fernando M, Schaff Hartzell V, Saran Nishant, Rowse Phillip G, Bagameri Gabor, Greason Kevin L, Daly Richard C, Guerrero Mayra, Crestanello Juan A. Outcomes of transatrial transcatheter mitral valve replacement with a balloon-expandable valve for severe mitral annular calcification.. JTCVS techniques. 2026. DOI: 10.1016/j.xjtc.2026.102197.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.